GlassScriptPhysician profile
Kaveh Khoobehi
NPI 1477828762
$7,295.01
in general payments reported to CMS, 2019-2025
52 companies · $1,236 in 2025
The $1,236 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $385 · 2021: $936 · 2022: $1,167 · 2023: $1,176 · 2024: $1,807 · 2025: $1,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,218.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,549.79 | 2021-2025 | |
| Ucb, INC. | $428.02 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Eisai INC. | $334.74 | 2022-2025 | |
| Acadia Pharmaceuticals INC | $308.56 | 2019-2024 | Nuplazid |
| Amgen INC. | $270.53 | 2019-2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $256.33 | 2020-2025 | Ultomiris, Soliris |
| Allergan, INC. | $181.58 | 2020 | |
| Mdd US Operations, LLC | $181.21 | 2019-2024 | Gocovri, Xadago, Apokyn |
| Argenx US, INC. | $178.19 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Novartis Pharmaceuticals Corporation | $168.59 | 2019-2025 | |
| Neurelis, INC. | $165.67 | 2020-2025 | Valtoco |
| Biohaven Pharmaceutical Holding Company LTD. | $158.52 | 2022 | |
| Lilly USA, LLC | $150.22 | 2019-2025 | Amyvid, Emgality, Reyvow |
| Pfizer INC. | $148.44 | 2024 | |
| Biogen, INC. | $132.26 | 2019-2025 | Tysabri, Vumerity, Plegridy |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaveh Khoobehi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.